Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis (Q34715649)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

0 references

1 reference

Europe PubMed Central

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis (English)

1 reference

Europe PubMed Central

4 August 2017

0 references

attention deficit hyperactivity disorder

0 references

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

author name string

Kim Peterson

1

1 reference

Europe PubMed Central

4 August 2017

Marian S McDonagh

2

1 reference

Europe PubMed Central

4 August 2017

Rongwei Fu

3

1 reference

Europe PubMed Central

4 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

17 November 2007

1 reference

Europe PubMed Central

4 August 2017

Psychopharmacology

1 reference

Europe PubMed Central

4 August 2017

197

1 reference

Europe PubMed Central

4 August 2017

1

1 reference

Europe PubMed Central

4 August 2017

1-11

1 reference

Europe PubMed Central

4 August 2017

https://scigraph.springernature.com/pub.10.1007/s00213-007-0996-4

0 references

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0996-4

21 January 2018

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0996-4

21 January 2018

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0996-4

21 January 2018

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0996-4

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and treatment of ADHD in adults in primary care.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy of adult ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A review of the economic burden of ADHD

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current methods of the US Preventive Services Task Force: a review of the process

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analyses involving cross-over trials: methodological issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bupropion SR in adults with ADHD: a short-term, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention Deficit Hyperactivity Disorder: manifestation in adulthood

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Driving impairments in teens and adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18026719

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-007-0996-4

1 reference

Europe PubMed Central

4 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34715649&oldid=1967094748"